Desmoid tumor (DT; other synonymously used terms: Desmoid-type fibromatosis, aggressive fibromatosis) is a rare and locally aggressive monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. Previously surgery was the standard primary treatment modality; however, in recent years a paradigm shift towards a more conservative management has been introduced and an effort to harmonise the strategy amongst clinicians has been made. We present herein an evidence-based, joint global consensus guideline approach to the management of this disease focussing on: molecular genetics, indications for an active treatment, and available systemic therapeutic options. This paper follows a one-day consensus meeting held in Milan, Italy, in June 2018 under the auspices of the European Reference Network for rare solid adult cancers, EURACAN, the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) as well as Sarcoma Patients EuroNet (SPAEN) and The Desmoid tumour Research Foundation (DTRF). The meeting brought together over 50 adult and pediatric sarcoma experts from different disciplines, patients and patient advocates from Europe, North America and Japan.

The management of desmoid tumours : A joint global consensus-based guideline approach for adult and paediatric patients / B. Alman, S. Attia, C. Baumgarten, C. Benson, J.-. Blay, S. Bonvalot, J. Breuing, K. Cardona, P.G. Casali, F. van Coevorden, C. Colombo, A.P. Dei Tos, P. Dileo, A. Ferrari, M. Fiore, A.M. Frezza, J. Garcia, R. Gladdy, M. Gounder, A. Gronchi, R. Haas, S. Hackett, F. Haller, P. Hohenberger, O. Husson, R.L. Jones, I. Judson, B. Kasper, A. Kawai, V. Kogosov, A.J. Lazar, R. Maki, T. Mathes, C. Messiou, F. Navid, Y. Nishida, E. Palassini, N. Penel, R. Pollock, D. Pieper, M. Portnoy, C.P. Raut, E. Roets, S. Sandrucci, M. Sbaraglia, S. Stacchiotti, K.A. Thornton, W. van der Graaf, K. van der Zande, W.J. van Houdt, V. Villalobos, A.J. Wagner, E. Wardelmann, M. Wartenberg, S. Watson, A. Weiss, N. Zafiropoulos. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 127(2020), pp. 96-107. [10.1016/j.ejca.2019.11.013]

The management of desmoid tumours : A joint global consensus-based guideline approach for adult and paediatric patients

P.G. Casali;
2020

Abstract

Desmoid tumor (DT; other synonymously used terms: Desmoid-type fibromatosis, aggressive fibromatosis) is a rare and locally aggressive monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. Previously surgery was the standard primary treatment modality; however, in recent years a paradigm shift towards a more conservative management has been introduced and an effort to harmonise the strategy amongst clinicians has been made. We present herein an evidence-based, joint global consensus guideline approach to the management of this disease focussing on: molecular genetics, indications for an active treatment, and available systemic therapeutic options. This paper follows a one-day consensus meeting held in Milan, Italy, in June 2018 under the auspices of the European Reference Network for rare solid adult cancers, EURACAN, the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) as well as Sarcoma Patients EuroNet (SPAEN) and The Desmoid tumour Research Foundation (DTRF). The meeting brought together over 50 adult and pediatric sarcoma experts from different disciplines, patients and patient advocates from Europe, North America and Japan.
CTNNB1; Desmoid tumour; Gardner syndrome; Medical therapy; Patient advocacy groups; Radiotherapy; SPAEN; Surgery; Treatment algorithm; β-catenin; Adult; Child; Combined Modality Therapy; Consensus; Disease Management; Fibromatosis, Aggressive; Humans; Practice Guidelines as Topic
Settore MED/06 - Oncologia Medica
Article (author)
File in questo prodotto:
File Dimensione Formato  
PIIS0959804919308329.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.07 MB
Formato Adobe PDF
1.07 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/809127
Citazioni
  • ???jsp.display-item.citation.pmc??? 61
  • Scopus 148
  • ???jsp.display-item.citation.isi??? 135
social impact